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Cytolytic T  lymphocytes  (CTL) a directed  against  murine  sarcoma  virus  (MSV) 
tumors  (1)  or any  other  tumor  bearing the C-type virus-induced  Friend, Moloney, 
Rauscher  (FMR) antigen (2) are H-2 restricted. It has been previously shown that in 
most  cases the products  of only one  region of the  H-2  complex are involved in  the 
CTL to tumor target cells interaction, i.e., D b in H-2 b and K d in H-2  d haplotypes, K b 
and  D d being  not  concerned  (3).  Similar phenomena  have  been  observed  in  other 
systems  with  nononcogenic  viruses  (4-6),  H-Y  (7),  other  minor  histocompatibility 
antigens  (8)  and  hapten-modified cells (9).  Several explanations of this very precise 
H-2  restriction  can  be  advanced:  (a)  The  association  of  FMR  and  certain  H-2 
molecules  (i.e.,  K b and  D d)  never  occurs  on  the  tumor  cell  surface.  (b)  The  CTL 
response  is  under  the  control  of classical I  region-associated immune  response  (Ir) 
genes with  dominant  responsiveness;  H-2 b mice,  for example,  being low  responders 
against K b +  FMR.  (c)  The response is directly controlled by genes mapping in the 
K  or D  regions, with complete immunodominance  of some viral 4-  H-2 associations 
so that in the presence of the immunodominant one (i.e., D b +  FMR  or K a +  FMR), 
the other associations existing on  the tumor cell surface are not  recognized by CTL 
precursors.  We  report  here  experiments  excluding the  first  hypothesis  and  strongly 
suggesting that it is the third hypothesis that  is correct in the FMR  tumor system. 
Materials  and  Methods 
Mice.  BALB/c,  C57BL/6  (B6),  C57BL/10  (B10),  B10.A(2R)  (2R),  B10.A(5R)  (5R), 
C3H.OL, HTG, HTI,  (5R ×  B10)F1, and  (5R  X B10.WB)FI hybrids were obtained from our 
colonies. (Institut National de la Sant~ et de la Recherche M~dicale, Paris). 
Viruses.  The MSV, Moloney isolate, was maintained by acellular transmission in newborn 
(B6 X BALB/c)FI, and the Moloney leukemia virus (MLV) in newborn BALB/c mice. 
Cells.  MBL2,  an  MLV-induced  lymphoma of B6  (H-2 b)  mice,  and  LSTRA,  an  MLV- 
induced lymphoma of BALB/c (H-2  a) mice, were maintained by intraperitoneal passage of l0  s 
cells in adult animals. Both of them bear the serologically defined viral FMR antigen. FMR(+) 
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5R  tumor  cells were  not  available, and  C-type virus-infected  fibroblasts,  macrophages,  and 
lymphocytes of adult mice are relatively bad targets and stimulator cells for the FMR system. 
All the experiments with 5R cells were therefore set up with lipopolysaccharide (LPS) blasts of 
adult  mice infected when  newborn  with  MLV, as described  recently  (V.  Duprez,  Y.  H~nin, 
and J.  P. L~vy. Manuscript  in preparation.).  Such blast  cells behave in serological and  ceil- 
mediated  reactions  like FMR  lymphoma  cells;  they  are,  however,  less  sensitive to  immune 
cytolysis. 
Immune Lymphocytes.  Immune spleen cells from mice inoculated intramuscularly with MSV 
were taken  10-15 d  after inoculation for primary chromium release tests (CRT), and 3-30 wk 
later for in vitro restimulation  by syngeneic  FMR(+)  cells.  Restimulation  was  performed  as 
previously described (2). 
CRT.  The CRT was performed as previously described  (2)  in microtiter plates  (Titertek; 
Flow Laboratories, Paris), with each well receiving 104 SlCr-labeled target cells and normal or 
immune  lymphocytes  so  that  the  effector:target  cell  ratio  varied  from  100:1  to  3:1.  The 
chromium release was measured after  18 h of incubation in primary and 4 h  of incubation  in 
secondary reactions. 
Competition Experiments.  The competition experiments were performed by adding increasing 
amounts of unlabeled competitor cells to the CRT mixture as described previously (2). 
Blocking by Anti-H-2 Sera.  Blocking by anti-H-2  sera  was  performed  with  cells previously 
incubated  for 20  min at  4°C with  1/2 diluted  sera  as targets  for the CRT  (3).  The sera were 
obtained  by  repeated  inoculations  of allogenic  spleen  cells  in  recipient  adult  mice.  Three 
different  sera  were  used:  anti-H-2b:  (BALB/c  ×  C3H/He)F1  anti-BALB.B;  anti-H-2Db: 
(B10.RIII ×  B10.Br)F~ anti-B10.A(4R);  and anti-H-2Kb:  B10.A anti-B10.A(5R). 
Results 
Table  I  shows  the  results  of a  typical  experiment  involving in  vivo primed  anti- 
MSV  T  killer cells and  H-2  b or H-2  a  lymphoma  target  cells.  It appears,  as described 
previously  (3),  that  MBL2  (H-2  b)  was killed only by CTL  sharing the D b specificity, 
and  LSTRA  (H-2  d) only by attacker  lymphocytes sharing d  specificities at the K  end 
of the  major  histocompatibility  complex  (MHC).  On  the  other  hand,  HTI  and  5R 
TABLE  I 
Cytolysis of H-2 b and H-2 a Lymphoma Cells By In  Vivo Primed Anti-MSV CTL from 
Different Lines 
Effector cells 
Immune spleen cell 
donors* 
H-2 haplotype 
Target Cells 
MBL2  LSTRA 
K  A  B  j  E  C  S  G  D  (H-2  b)  (H-2  d) 
C57BL/6 anti-MSV  b  b  b  b  b  b  b  b  b  47:]:  4 
B10.A(2R)  anti-MSV  k  k  k  k  k  d  d  --  b  36  6 
BALB/canti-MSV  d  d  d  d  d  d  d  d  d  3  32 
C3H.OL anti-MSV  d  d  d  d  d  d  k  k  k  0  21 
B10.A(5R)  anti-MSV  b  b  b  k  k  d  d  d  d  0  0 
HTGanti-MSV  d  d  d  d  d  d  d  --  b  23  19 
HTIanti-MSV  b  b  b  b  b  b  b  --  d  5  3 
* Effector cells have been taken from the spleen of MSV-infected mice 10-15 d after infection 
of 0.1 ml of 1:100 diluted MSV. 
:~ Percent chromium release from target cells with effector:target cell ratio of 100:1 and after 
an 18-h incubation period. The mean standard errors being always between 0.4 and 2% are 
not given. In all cases, the activity of immune CTL was calculated by comparison with the 
activity of normal lymphoid cells of the same inbred strains.  Practically no differences were 
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lymphocytes  (KbD  d)  failed to lyse MBL2  and  LSTRA,  whereas  HTG  (KdD  b)  CTL 
were efficent against both. These results show the exclusive involvement of K d or O b 
molecules in  the interaction between  H-2 d or H-2 b lymphocytes and  their syngeneic 
FMR(+)  target cells, as also shown by blocking experiments with monospecific anti- 
H-2 sera (3). 
The lack of detectable reactivity of in vivo primed 5R lymphocytes against H-2K h 
+  FMR  or  H-2D  d  +  FMR  could  be  a  result  of  the  weakness  of such  reactions. 
Secondary stimulations were  therefore necessary to  test  this point.  As mentioned  in 
Materials  and  Methods,  5R  lymphoma  cells  bearing  the  FMR  antigen  were  not 
available. LPS blast cells of 5R  mice infected with  MLV  at  the  time of birth  were 
therefore used following a  recently developed method  (V.  Duprez,  H.  H~nin,  and J. 
P.  Lfivy. Manuscript  in preparation.). Table II shows  the results of a  typical experi- 
ment:  B6 lymphocytes in vivo primed with  MSV and  then  in  vitro restimulated by 
syngeneic  FMR(+)  cells  lysed  B6  (KbD  b)  but  not  5R  (KbD  d)  target  cells,  thus 
confirming  that  B6  mice  react  only with  D b  +  FMR.  Similarly, BALB/c-immune 
lymphocytes lysed syngeneic (KdD  d)  targets but  not  5R  FMR(+)  blast cells (KbDd), 
which  shows  that  they react only with  K d 4-  FMR.  On  the other hand,  5R  effector 
cells twice stimulated in syngeneic conditions lysed both 5R and B6 FMR(+),  but not 
BALB/c FMR(+),  target cells. The 5R anti-FMR CTL cells therefore react with  K b 
+  FMR  but  not  with  D d 4-  FMR.  Controls with  uninfected  blasts demonstrate  the 
specificity of the reactions both  at  the level of stimulation and  at  the effector steps. 
Anti-Thy-l.2  and  complement  treatment  completely  abolish  the  activity  of  the 
effector cells, which confirms their thymic origin (results not shown). 
Competition experiments have been performed to confirm these results. When  5R 
attacker cells were tested against labeled syngeneic MBL2 cells, the chromium release 
was inhibited by an excess of 5R FMR(+)  blast cells as well as MBL2 tumor cells but 
not  by  4R  FMR(+)  blasts  (KkD  b)  (Fig.  1A),  thus  confirming  that  5R  anti-FMR 
lymphocytes recognized the K b 4- FMR  association on  both  5R  and  B6  target  cells. 
In  contrast,  when  B6  anti-FMR  T  killer cells and  labeled MBL2  target  cells were 
TAnL~  II 
Cytolysis of FMR( + )  Target  Cells By In  Vivo Primed and In  Vitro Restimulated Anti-MSV CTL 
Effcctor cells*  Talgct cells 
E['fect ol :ta)gct 
In  vitlo stimulation  cell ratios  B6  B,.~.I.B/c  Notrnal  5R 
Immune donol spleen cells  with  MB[,2  M  Mu[,V:~  I,STR.X  M.MuLV{  5R{  Xl Mid,\'~z 
B6 anti-MSV  MBL2  100:1  40§  16  0  0  0  0 
30:1  26  14  0  0  0  0 
BALB/c anti-MSV  LSTRA  100:1  0  0  34  30  0  0 
30:1  0  0  21  18  0  0 
5R anti-MSV  Normal 5R~  100:1  0  NTI]  0  NT  0  0 
30:1  0  NT  0  NT  0  0 
5R anti-MSV  5R M.MuLV:~  100:1  36  20  0  0  0  33 
30:1  19  12  0  0  0  16 
* 8 X  10  6 spleen cells from MSV-infected mice taken 6-10 wk after infection and cocultivated 6 d with  1 
X 10  6 irradiated stimulating cells. 
:~ Spleen cells of MLV-infected mice or normal spleen cells incubated  with LPS for 48 h. MuLV,  routine 
leukemia virus. 
§ Percent chromium release from target ceils after 4 h of incubation. 
II Not tested. E.  GOMARD,  Y.  HI~NIN,  M.  J.  COLOMBANI, AND J.  p.  LI~VY 
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FIc.  1.  Competition experiments with different unlabeled competitors and MBL2 as ~Cr-labeled 
target cells. (A) Effector cells: B6 anti-MSV CTL in vitro restimulated by MBL2 cells. (B) Effector 
ceils: 5R anti-MSV CTL in vitro restimulated by MLV-infected 5R LPS blast cells. Effector:MBL2 
target cell ratio: 100:1. 
TABLE  III 
Cytolysis of MBL2  Target  Cells By 5R or B6 Effector  Cells: Selective Effect of Anti-H-2K n and 
Anti-H-2D n Sera 
MBL2 target cells preincubated with  Effector cells 
Serum  Specificity  B6*  5R:[: 
-  -  30§  11 
Normal mouse serum  --  32  13 
(BALB/c × C3H)FI anti-BALB.B  Anti-H-2  h  2  0 
(BI0.RIII ×  B10.BR)FI  anti-Bl0.A(4R)  Anti-H-2D  b  4  12 
BI0.A anti-B 10.A(5R)  Anti-H-2K"  41  0 
* B6 anti-MSV CTL in vitro restimulated by MBL2. Effector:target cell ratio of 20:1. 
:1: 5R anti-MSV CTL in vitro restimulated by MLV-infected 5R LPS blast  cells. Effector:target cell ratio 
of 100:1. 
§ Percentage of specific chromium release of the target cells calculated by comparison with the activity of 
normal lymphoid cells in the presence of the same normal or immune serum. 
used, competitions were obtained by B6 or 4R FMR(+)  blasts or by MBL2  cells, but 
not  by  5R  FMR(+)  cells,  (Fig.  1 B),  thus  showing  that  B6  lymphocytes  react 
exclusively with D b +  FMR  on B6 target  cells. 
Finally,  blocking  experiments  were  done  with  anti-H-2K b  and  anti-H-2D b  sera. 
Table II! shows that  the cytolysis of MBL2  target  cells by 5R CTL  was  inhibited  by 
anti-K  b but  not by anti-D  b antibodies.  As expected, the reverse was observed with B6 
effectors and  the same MBL2  target  cells. 
These  results  show  that  both  K b  +  FMR  and  D b  +  FMR  antigenic  associations 
exist on B6 FMR(+)  tumor cells. The  K b +  FMR  association  might be, however, less 1472  IMMUNE  RESPONSE  GENES  CONTROL  T  KILLER  CELL  RESPONSE 
antigenic because it can be revealed only after secondary stimulation. The weakness 
of this antigen is also emphasized by the rapid disappearance of memory cells: whereas 
anti-D  b +  FMR T  killer  lymphocytes are  easily  induced  in  B6  mice  by secondary 
stimulation at least  up to 8 mo after immunization, anti-K  b +  FMR responses have 
been rarely detected in 5R mice later than 2 mo post-inoculation (Table IV). 
The ability to react or not react with K b 4- FMR is thus genetically determined; B6 
and B10 mice being nonresponder in contrast to 5R mice. Table V  shows that  (B10 
×  5R)F1  cells  in vivo primed with MSV react at a  good level  against MBL2 targets, 
like  the B10 parent,  whereas  5R cells  never produced detectable primary response. 
After secondary in vitro stimulation by MBL2, (Kb/bob/d)F1  hybrids produced a very 
high  anti-MBL2  response,  which  contrasts  with  a  weak  and  possibly  insignificant 
reaction against  5R FMR(+)  blast  cells.  Therefore,  they react  preferentially,  if not 
exclusively, with D b +  FMR. When in vitro restimulated with 5R FMR(+) blast cells 
instead of MBL2, (B 10 ×  5R)F1 mice produced only a weak anti-K  b +  FMR cytolysis 
that was hardly detectable on 5R target cells, whereas 5R mice produced a good level 
of anti-K  b +  FMR activity.  (5R  ×  B10.WB)FI hybrids, which share with  B10 and 
(5R ×  B 10)Fx mice the H-2D  b private specificity but differ by the other regions of the 
MHC, behave exactly like (5R ×  B10)F1 mice. 
Discussion 
We have previously shown  that  the  anti-FMR  response  of H-2 b  or  H-2  d mice  is 
very precisely restricted so that the FMR antigen is seen associated with H-2D  b or H- 
2K  d molecules but never with H-2K  b or H-2D  d (3). The above reported results show 
at first  that this is not a result of the absence of association between H-2K  b and FMR 
because  5R-immune CTL cells  react  exclusively with  K b +  FMR,  not  only on 5R 
FMR(+) blast cells,  but also on MBL2 (H-2  b)  tumor cells.  Both K b +  FMR and  D b 
+  FMR antigenic associations, therefore, exist  on the surface of B6 tumor cells,  and 
the choice of the reacting association depends only upon the 5R or B6 origin of the 
TABLE  IV 
Secondary Anti-FMR CTL Response in B6 and BIO.A (5R) Mice at Different Times After MSV 
Inoculation 
Effector cells*  Stimulator cells:~ 
Target cells 
Time 
after  5R 
MBL2  LSTRA  MSV in-  M.MuLV§ 
oculation 
100:1  30:1  100:1  30:1  100:1  30:I 
B6 anti-MSV  MBL2 
5R anti-MSV  5R MLV-infected blast cells 
1 mo  73  55  37  9  0  0 
3 mo  75  66  10  0  0  0 
6 mo  70  59  12  0  0  0 
10 mo  57  47  20  3  0  0 
1 mo  31  26  0  0  33  24 
2 mo  23  17  0  0  12  7 
4 mo  5  0  0  0  0  0 
6 mo  0  0  0  0  0  0 
* Spleen cells from MSV-infected mice taken  1 to  10 months after virus inoculation. 
:~ 8 ×  106 effector cells cultivated 6 days with 1.106 stimulating cells. 
§ Spleen cells from neonatally infected mice incubated with LPS for 48 h.  MuLV, murine leukemia virus. E.  GOMARD,  Y.  HI~NIN, M. J.  COLOMBANI, AND j.  P.  LI~VY 
TABLE V 
Cytolytic Activity of Anti-MSV CTL from (5R X  BIO)F1 or (5R X  BIO. WB)FI 
1473 
Effector cells 
Immune spleen cell  In vitro restimulation 
donors*  with:~ 
Target cells 
5R  MBL2  LSTRA  M.MuLV§ 
100:1  30:1 100:1 30:1 100:1 30:1 
Experiment A 
Experiment B 
B  10 anti-MSV 
BALB/c anti-MSV  -- 
5R anti-MSV 
(5R  ×  B10)F~ anti-  -- 
MSV 
(5R  ×  B10.WB)Ft  -- 
anti-MSV 
B 10 anti-MSV  MBL2 
BALB/c anti-MSV  LSTRA 
5R anti-MSV  5R  MLV-infected blast 
cells 
(5R  X BI0)Fx anti-  MBL2 
MSV 
(5R  X Bl0)Fl  anti-  5R  MLV-infected blast 
MSV  cells 
(5R  ×  BI0.WB)F~  BI0.WB MLV-infected 
anti-MSV  blast cells 
(5R  X  BI0.WB)F1  5R  MLV-infected blast 
anti-MSV  cells 
32*  13  6  0  NTI[ NT 
0  0  27  11  NT  NT 
0  0  0  0  NT  NT 
29  8  0  0  NT  NT 
38  11  2  0  NT  NT 
49  36  5  0  5  0 
0  0  60  43  0  0 
35  28  0  0  18  13 
51  39  3  0  6  0 
8  5  0  0  6  0 
22  11  0  0  0  0 
3  0  0  0  0  0 
* Spleen cells from MSV-infected mice taken 8-10 wk after virus  inoculation. 
:[: 8 ×  10  e effector cells cultivated 6 d with 1 ×  106 stimulating cells. 
§ Spleen cells of neonatally infected mice incubated with LPS for 48 h. MuLV, murine leukemia virus. 
II Not tested. 
attacker cells used. In other words, the mechanism of H-2 restriction must be related 
to the problem ofT cell repertoire and cannot be explained by a phenomenon arising 
only on the target cell surface, such as a  specific association between H-2 and FMR 
antigens. This conclusion is apparently at variance with previously published obser- 
vations that suggest that a  specific association exists between D b and viral structures, 
because  H-2D  b,  but  not  H-2K  b,  molecules  have  been  detected  in  Friend  virions 
produced in H-2  b cells (10). This discrepancy can be explained in at least two ways: 
(a)  The  presence of H-2  molecules in  the  virions does  not  necessary correlate  the 
existence of a  specific CTL-reacting structure on the virus-producer cell surface.  (b) 
The relative unsensitivity  of the method used to detect virion-associated H-2 antigens 
could explain that a  lesser but significant amount of K b molecules might have been 
missed in the virions. A  specific cocapping of H-2D  b and FMR  molecules has also 
been reported (11, 12), although not confirmed in other experiments with the same or 
other methodologies (2, 13). Quantitative problems or the use of different cells perhaps 
explain this discrepancy. Furthermore, the cocapping phenomenon might be unre- 
lated to the CTL-reacting structure of the cell surface that is directly explored by the 
present experiments. 
There  exists  an  obvious  hierarchy  of  FMR  +  H-2  antigenic associations,  and 1474  IMMUNE  RESPONSE GENES CONTROL  T  KILLER CELL RESPONSE 
whatever the nature of this association D b is preferred to K b, K b to D d, and K d to D d. 
The mouse CTL response  is,  however,  not  obligatorily  limited  to  a  unique  H-2  + 
FMR association as shown in HTG mice that react with both D b +  FMR and K d + 
FMR.  It cannot be excluded  that  D d antigens can be seen in association with FMR 
in other H-2 haplotypes because H-2Dd-restricted CTL responses have been observed 
in other tumors (14,  15). It is, however, interesting to observe that the D d +  antigen 
association was only weakly antigenic in these cases, not being revealed in a primary 
response. Similar response hierarchies have now been observed in all kinds of T  killer 
cell-mediated syngeneic reactions as with  nononcogenic viruses  (4-6),  H-Y antigens 
(7) and hapten-modified cells (9). The reason for this phenomenon is unclear.  In the 
FMR system, the possible existence of low responder alleles of Ir genes that control 
the nonreacting associations in all inbred strains tested appears unlikely because:  (a) 
previously published results have shown that the non-H-2 background is not involved 
in the restriction phenomenon  (3)  excluding the role of non-H-2-1inked Ir genes;  (b) 
the use of H-2 recornbinants and experiments with multiple F~ hybrids of different H- 
2  specificities  failed  to  reveal  any  complementation  of the  response,  which  could 
suggest the role of I region-associated Ir genes (E. Gomard, Y. H~nin, and J. P. L~vy. 
Unpublished  data.);  and  (c)  furthermore,  the  above reported  observation  that  the 
ability to respond  against  K b +  FMR  is  recessive in  (5R  ×  BI0)F1  hybrids  argues 
against the existence of a classical I region-associated Ir gene with dominant  respon- 
siveness in K b 4- FMR responder 5R mice. On the other hand, the anti-K  b +  FMR 
response  appears  to  be observed  only  in  mice  not  bearing  the  O b specificity.  The 
results obtained with (5R ×  B 10)F1 show that the anti-K  ~ +  FMR response is recessive 
in these hybrids. With similar results being obtained with  (5R  ×  B10.WB)F1,  which 
share only the D region with B 10, one may suppose that the responsible gene maps to 
this D  region.  Further  experiments are now in  progress to further demonstrate this 
point. A similar interpretation  has been proposed for D  or K  region-associated genes 
that control CTL responses in nononcogenic systems (4, 5).  Such genes could provoke 
an immunodominance of certain H-2 +  viral antigen associations. In other words, the 
presence of D b +  FMR, for example, could abolish the possibility to respond against 
K b 4- FMR.  Such a selection of a subpopulation of responder T  killer cells might be 
compared with the dominant  idiotype clones in certain  antibody responses (16,  17). 
In terms of altered self,  the receptor for D b 4- FMR could be more efficient that any 
other.  In terms of dual recognition, it could be imagined that CTL that bear an H- 
2D b self receptor would  be able to develop an antigen  receptor specific for FMRof 
higher affinity than the precursors that bear a receptor for H-2K  b or H-2D  a self.  The 
results  observed  in  the  FMR  system  might  be  especially  interesting,  because  they 
suggest that the antigenic association chosen for the response is the one providing the 
higher level of protection: mice that respond against O b 4- FMR regularly produce a 
good  level  of CTL after primary immunization,  and  they  possess  memory cells  at 
least 8  mo later.  In contrast,  5R  mice that  are obliged  to respond against  a  weaker 
antigenic association  (i.e.,  K b 4- FMR)  produce CTL activity after secondary stimu- 
lation  only.  Furthermore,  memory cells disappear early in  this case.  (5R  X  B10)Fa 
hybrids are low responders against K b 4- FMR, responsiveness against this association 
being recessive, but they produce a primary anti-FMR response associated to D b, like 
the  high-responder  B10  patient,  the  high  level  of antiviral  responses  is  therefore 
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The apparent discrepancy existing between the usual dominant  responsiveness at 
Ir genes of the antibody responses and the dominant unresponsiveness against certain 
H-2 +  viral antigens (i.e., K b +  FMR) for K or D region-associated CTL that control 
genes (Results [4]) is probably a result of the double subsets of precursors that exist in 
the latter case even in homozygous mice. As a  matter of fact, CTL precursors can 
respond  against  the  antigen  associated  to  either  H-2D or  H-2K.  The situation  is 
similar to that of an F1 hybrid between responder and nonresponder parents in the 
antibody response.  In this case,  F1  hybrids respond preferentially with  the antigen 
associated  to  Ia  of the  responder  parent  (18,  19).  Ir  genes  that  control  CTL  or 
antibody responses, therefore, are both characterized by (a) dominant high-responder 
phenotype and (b) the choice of the best possible MHC product +  antigen association, 
explaining unresponsiveness against  certain associations and  permitting dominance 
of the higher response. They seem to differ only by their mapping to different regions 
of the H-2 complex. 
Summary 
Cytolytic T  lymphocytes (CTL) specific for the virus-induced and leukemia-asso- 
ciated Friend, Moloney, Rauscher  (FMR)  antigen are easily detected in the spleens 
of primary and secondary stimulated  H-2  b or H-2  d mice. They react,  respectively, 
with H-2D  b +  FMR and H-2K  d +  FMR;  D d and K b never being involved. On the 
other hand,  recombinant  (KbD  d)  mice are  relatively low  responders  that  produce 
CTL only after secondary stimulation. Competition and blocking experiments with 
monospecific anti-H-2 antibodies have demonstrated that  on the same H-2  b tumor 
cells, C57BL/6 (H-2  b)  lymphocytes recognize D b +  FMR, whereas B I0.A(5R)  lym- 
phocytes recognize K b +  FMR, the restriction cannot, therefore, be explained by a 
specific association of viral molecules with certain H-2 products. The CTL response 
of (B 10 ×  5R)F1 hybrids is (a) easily detected in primary reaction, the high responder 
anti-FMR phenotype being dominant and  (b) directed against  D b +  FMR, F~ mice 
being low responder against  K b +  FMR  like the B10 parent. These results suggest 
that  a  D  region-associated  immune  response  gene controls the  cell-mediated anti- 
FMR reaction, the best available H-2 +  FMR antigenic association being chosen by 
CTL precursors. 
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